Daniel Aletaha

Daniel Aletaha

Medizinische Universität Wien

H-index: 98

Europe-Austria

About Daniel Aletaha

Daniel Aletaha, With an exceptional h-index of 98 and a recent h-index of 63 (since 2020), a distinguished researcher at Medizinische Universität Wien,

His recent articles reflect a diverse array of research interests and contributions to the field:

Amino Acids Fueling Fibroblast‐Like Synoviocyte Activation and Arthritis By Regulating Chemokine Expression and Leukocyte Migration

P160 Drug survival in SLE: real world data from the vienna lupus cohort

Bona fide dendritic cells are pivotal precursors for osteoclasts

Immunogenicity and safety of COVID-19 booster vaccination: A population-based clinical trial to identify the best vaccination strategy

Determination of the most appropriate ACR response definition for contemporary drug approval trials in rheumatoid arthritis

Selectivity, efficacy and safety of JAKinibs: new evidence for a still evolving story

The influence of biological DMARDs on aseptic arthroplasty loosening: a retrospective cohort study

Treat-to-target recommendations in giant cell arteritis and polymyalgia rheumatica

Daniel Aletaha Information

University

Medizinische Universität Wien

Position

Professor of Rheumatology

Citations(all)

67020

Citations(since 2020)

32255

Cited By

47628

hIndex(all)

98

hIndex(since 2020)

63

i10Index(all)

255

i10Index(since 2020)

205

Email

University Profile Page

Medizinische Universität Wien

Top articles of Daniel Aletaha

Title

Journal

Author(s)

Publication Date

Amino Acids Fueling Fibroblast‐Like Synoviocyte Activation and Arthritis By Regulating Chemokine Expression and Leukocyte Migration

Arthritis & Rheumatology

Thomas Karonitsch

Victoria Saferding

Markus Kieler

Karolina von Dalwigk

Anela Tosevska

...

2024/1/17

P160 Drug survival in SLE: real world data from the vienna lupus cohort

Daniel Mrak

Julia Pacher

Lena Reischmann

Peter Weber

Kastriot Kastrati

...

2024/3/1

Bona fide dendritic cells are pivotal precursors for osteoclasts

Annals of the Rheumatic Diseases

Antonia Puchner

Elisabeth Simader

Victoria Saferding

Melanie Hofmann

Markus Kieler

...

2024/4/1

Immunogenicity and safety of COVID-19 booster vaccination: A population-based clinical trial to identify the best vaccination strategy

Journal of Clinical Virology

Daniela Sieghart

Claudia A Hana

Caroline Dürrschmid

Leonhard X Heinz

Helmuth Haslacher

...

2024/8/1

Determination of the most appropriate ACR response definition for contemporary drug approval trials in rheumatoid arthritis

Annals of the Rheumatic Diseases

Victoria Konzett

Andreas Kerschbaumer

Josef S Smolen

Daniel Aletaha

2024/1/1

Selectivity, efficacy and safety of JAKinibs: new evidence for a still evolving story

Michael Bonelli

Andreas Kerschbaumer

Kastriot Kastrati

Kamran Ghoreschi

Massimo Gadina

...

2024/2/1

The influence of biological DMARDs on aseptic arthroplasty loosening: a retrospective cohort study

Rheumatology

Markus M Schreiner

Jennifer Straub

Sebastian Apprich

Kevin Staats

Reinhard Windhager

...

2023/7/4

Treat-to-target recommendations in giant cell arteritis and polymyalgia rheumatica

Annals of the rheumatic diseases

Christian Dejaco

Andreas Kerschbaumer

Daniel Aletaha

Milena Bond

Elvis Hysa

...

2024/1/1

FAPi PET/CT for assessment and visualisation of active myositis-related interstitial lung disease: a prospective observational pilot study

Eclinicalmedicine

Kastriot Kastrati

Thomas S Nakuz

Oana C Kulterer

Irina Geßl

Elisabeth Simader

...

2024/6/1

Definition of rheumatoid arthritis flare based on SDAI and CDAI

Annals of the Rheumatic Diseases

Victoria Konzett

Andreas Kerschbaumer

Josef S Smolen

Eirik Klami Kristianslund

Sella A Provan

...

2024/2/1

Unmet need in rheumatology: reports from the Advances in Targeted Therapies meeting, 2023

Annals of the rheumatic diseases

Kevin L Winthrop

Philip Mease

Andreas Kerschbaumer

Reinhard E Voll

Ferdinand C Breedveld

...

2024/4/1

Evidence on treat to target strategies in polymyalgia rheumatica and giant cell arteritis: a systematic literature review

Elvis Hysa

Milena Bond

Lisa Ehlers

Dario Camellino

Louise Falzon

...

2024/2/1

P117 Efficacy of filgotinib in patients with rheumatoid arthritis: Week 156 results from a long-term extension study

Maya H Buch

Daniel Aletaha

Roberto Caporali

Bernard Combe

Hendrik Schulze-Koops

...

2024/4/1

Efficacy and safety of pharmacological treatment of psoriatic arthritis: a systematic literature research informing the 2023 update of the EULAR recommendations for the …

Andreas Kerschbaumer

Josef S Smolen

Ricardo JO Ferreira

Heidi Bertheussen

Xenofon Baraliakos

...

2024/3/19

Efficacy of baricitinib in patients with moderate-to-severe rheumatoid arthritis up to 6.5 years of treatment: results of a long-term study

Rheumatology

Roberto Caporali

Peter C Taylor

Daniel Aletaha

Raimon Sanmartí

Tsutomu Takeuchi

...

2024/1/22

EULAR recommendations for the management of psoriatic arthritis with pharmacological therapies: 2023 update

Annals of the rheumatic diseases

Stephanie Shoop-Worrall

2024/2/26

Impact of muscle biopsy on the clinical decision-making process in patients with suspected idiopathic inflammatory myopathy

Journal of Autoimmunity

Kastriot Kastrati

Nasim Nakhost Lotfi

Marwa G Tawfik

Ellen Gelpi

Simon Hametner

...

2024/4/1

Assessment-Tools in der Rheumatologie

Zeitschrift für Rheumatologie

Daniel Aletaha

2023/6

Efficacy, duration of use and safety of glucocorticoids: a systematic literature review informing the 2022 update of the EULAR recommendations for the management of rheumatoid …

Sytske Anne Bergstra

Alexandre Sepriano

Andreas Kerschbaumer

Désirée Van Der Heijde

Roberto Caporali

...

2023/1/1

Safety and immunogenicity of a third COVID-19 vaccination in patients with immune-mediated inflammatory diseases compared with healthy controls

Annals of the Rheumatic Diseases

Felix Kartnig

Daniel Mrak

Elisabeth Simader

Selma Tobudic

Helga Radner

...

2023/2/1

See List of Professors in Daniel Aletaha University(Medizinische Universität Wien)

Daniel Aletaha FAQs

What is Daniel Aletaha's h-index at Medizinische Universität Wien?

The h-index of Daniel Aletaha has been 63 since 2020 and 98 in total.

What are Daniel Aletaha's top articles?

The articles with the titles of

Amino Acids Fueling Fibroblast‐Like Synoviocyte Activation and Arthritis By Regulating Chemokine Expression and Leukocyte Migration

P160 Drug survival in SLE: real world data from the vienna lupus cohort

Bona fide dendritic cells are pivotal precursors for osteoclasts

Immunogenicity and safety of COVID-19 booster vaccination: A population-based clinical trial to identify the best vaccination strategy

Determination of the most appropriate ACR response definition for contemporary drug approval trials in rheumatoid arthritis

Selectivity, efficacy and safety of JAKinibs: new evidence for a still evolving story

The influence of biological DMARDs on aseptic arthroplasty loosening: a retrospective cohort study

Treat-to-target recommendations in giant cell arteritis and polymyalgia rheumatica

...

are the top articles of Daniel Aletaha at Medizinische Universität Wien.

What is Daniel Aletaha's total number of citations?

Daniel Aletaha has 67,020 citations in total.